Your institution may have access to this item. Find your institution then sign in to continue.
Title
New molecular entities.
Abstract
Discusses novel drugs from different companies approved in the U.S. Ventavis, a prostacyclin for pulmonary arterial hypertension from Cotherix Co.; Lunesta, a prescription sleep aid from Sepracor Inc.